<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04068363</url>
  </required_header>
  <id_info>
    <org_study_id>IBR/0006379</org_study_id>
    <nct_id>NCT04068363</nct_id>
  </id_info>
  <brief_title>Donor Gender Effect on Graft Function in Adult Egyptian Patients Undergoing Living Donor Liver Transplant</brief_title>
  <official_title>Donor Gender Effect on Graft Function in Adult Egyptian Patients Undergoing Living Donor Liver Transplant: A Single Centre Retrospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Liver transplantation (LT) represents the gold-standard therapy for the treatment in case of
      dreadful liver pathologies . It is thus a main concern to optimize the results in terms of
      post-LT survivals. The effect of gender match on post-transplant outcome is still debatable.
      Hormonal , and size difference between female and male may be proposed to affect the post
      transplant outcome . The aim of this study is to evaluate the effect of donor-recipient
      gender mismatch on survival rates
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 15, 2019</start_date>
  <completion_date type="Anticipated">March 20, 2020</completion_date>
  <primary_completion_date type="Actual">February 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>2 years survival post liver transplant.</measure>
    <time_frame>3 months</time_frame>
    <description>The primary outcome will be survival at 2 years post liver transplant</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Donor to Recipient Gender Mismatch in LDLT</condition>
  <arm_group>
    <arm_group_label>Matched group</arm_group_label>
    <description>Same sex of both donor and recipient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mismatched group</arm_group_label>
    <description>Sex mismatch between donor and recipient, subgroups might be added</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>non interventional</intervention_name>
    <description>non interventional study</description>
    <arm_group_label>Matched group</arm_group_label>
    <arm_group_label>Mismatched group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Intraoperatively, Both standard anesthetic and piggyback liver transplant for hepatic
        transplantation will be performed by the same anesthesia and surgical team . Intraoperative
        hemodynamics (MAP and HR), graft weight to recipient weight ratio (GWRWR), blood products
        transfused and intraoperative adverse events will be recorded. At the end of surgery
        patients will be transferred to the ICU where they will be monitored and will receive the
        standard protocol for postoperative management after liver transplantation.

        - Recipients will be divided into two groups ( matched and mismatched) and will be
        subdivided based on the following variables: recipient age, MELD score, intraoperative
        packed red blood cells (PRBC) and fresh frozen plasma (FFP) transfusions, duration of cold
        ischemia. These subgroups will be compared with respect to 2-year graft survival separately
        in recipients of sex matched and mismatched transplantation.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult Egyptian Patients &gt;18 years.

        Exclusion Criteria:

          -  Patient refusal.

          -  Patients who underwent re-transplantation before discharge from the ICU after the
             first liver transplant.

          -  Intraoperative cardiac arrest or immediately postoperative cardiac arrest within the
             first 6 hours postoperative.

          -  Massive blood loss.

          -  Pre-existing renal failure requiring hemodialysis or continuous hemofiltration.

          -  Pregnancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hanaa A ELGENDY</last_name>
    <phone>+201001029544</phone>
    <email>hanaa.elgendy@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hanaa El Gendy</name>
      <address>
        <city>Cairo</city>
        <state>Ain Shams University Specialized Hospital</state>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hanaa Abdalla ElGendy</last_name>
      <phone>0100 102 9544</phone>
      <email>Hanaa.elgendy@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>August 20, 2019</study_first_submitted>
  <study_first_submitted_qc>August 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2019</study_first_posted>
  <last_update_submitted>February 28, 2020</last_update_submitted>
  <last_update_submitted_qc>February 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Hanaa Mohamed Abdallah ElGendy MD</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

